BrainStorm Cell Therapeutics
BCLI
#10185
Rank
NZ$11.71 M
Marketcap
$2.05
Share price
-6.50%
Change (1 day)
-87.32%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -NZ$16.19 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$43.38 Million, an increase over its 2021 earnings that were of -NZ$43.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$16.19 Million
2022 -NZ$43.38 Million-0.74%
2021 -NZ$43.7 Million-23.12%
2020 -NZ$56.84 Million36.8%
2019 -NZ$41.55 Million66.71%
2018 -NZ$24.93 Million181.66%
2017 -NZ$8.85 Million-0.6%
2016 -NZ$8.91 Million-41.31%
2015 -NZ$15.17 Million-8.22%
2014 -NZ$16.53 Million89.74%
2013 -NZ$8.71 Million42.27%
2012 -NZ$6.13 Million-12.45%
2011 -NZ$7 Million63.04%
2010 -NZ$4.29 Million35.52%
2009 -NZ$3.17 Million-48.99%
2008 -NZ$6.21 Million-44.39%
2007 -NZ$11.16 Million
2005 -NZ$5.78 Million-91.44%
2004 -NZ$67.51 Million94007.62%
2003 -NZ$0.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$1.23 B-7,086.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.06 Billion 5,869.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.42 Billion 7,905.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.40 B-19,399.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 1,060.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.46 Billion 2,486.97%๐Ÿ‡บ๐Ÿ‡ธ USA